Expression of cyclooxygenase-1 and -2 in extra-hepatic cholangiocarcinoma

Hepatobiliary and Pancreatic Diseases International

Volumn 1, Issue 3, 2002, Pages 429-433

  Wu, Gao Song ^a   Wang, Ju Hua ^a   Liu, Zheng Ren ^a   Zou, Sheng Quan ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Carcinogenes; Cholangiocarcinoma; Cyclooxygenase; Immunohistochemistry

Indexed keywords

AVIDIN; BIOTIN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ISOENZYME; POLYCLONAL ANTIBODY;

ADULT; AGED; ANTIBODY SPECIFICITY; ARTICLE; BILE DUCT; BILE DUCT CARCINOMA; CARCINOGENESIS; CHEMOPROPHYLAXIS; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; TUMOR DIFFERENTIATION;

ADULT; AGED; BILE DUCT NEOPLASMS; BILE DUCTS, EXTRAHEPATIC; CHOLANGIOCARCINOMA; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; LYMPHATIC METASTASIS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; STAINING AND LABELING;

EID: 0038143369     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Vane J. Towards a better aspirin. Nature 1994;367: 215-216.
2. Williams CS, Smalley W, DuBois RN. Aspirin use and potential mechanisms for colorectal cancer prevention. J Clin Invest 1997;100:1325-1329.
3. Weaver SA, Russo MP, Wright KL, et a]. Regulatory role of phosphatidylinositol 3-kinase on TNF-alpha-induced cyclooxygenase 2 expression in coloniz epithelial cells. Gastroenterology 2001; 120: 1117-1127.
4. Charles E, Eberhart RJ, Robert JC, et al. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 1994;107:1183-1188.
5. Leung WK, To KF, Ng YP, et al. Association between cyclo-oxygenase-2 overexpression and missense p53 mutations in gastric cancer. Br J Cancer 2001 84:335-339.
6. Zimmermann KC, Sarbia M, Weber AA, et al. Cyclooxygenase-2 expression in human esophageal carcinoma. Cancer Res 1999;59:198-204.
7. Yao R, Rioux N, Castonguay A, et al. Inhibition of COX-2 and induction of apoptosis: two determinants of nonsteroidal anti-inflammatory drugs' chemopreventive efficacies. Exp Lung Res 2000;26:731-742.
8. Gupta S, Srivastava M, Ahmad N, et al. Lipoxygenase-5 is overexpressed in prostate adenocarcinoma. Cancer 2001;91:737-743.
9. Smith WL, Marneet U. Prostaglandin endoperoxide synthase: structure and catalysis. Biophys Acta 1991; 1083:1-17.
10. Fantappie O, Masini E, Sardi I, et al. The MDR phenotype is associated with the expression of COX-2 and iNOS in a human hepatocellular carcinoma cell line. Hepatology 2002;35:843-852.
11. Kakiuchi Y, Tsuji S, Tsujii M, et al. Cyclooxygenase-2 activity altered the cell-surface carbohydrate antigens on colon cancer cells and enhanced liver metastasis. Cancer Res 2002;62:1567-1572.
12. Oshima M, Murai N, Kargman S, et al, Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor. Cancer Res 2001;61:1733-1740.
13. Gately S. The contributions of cyclooxygenase-2 to tumor angiogenesis. Cancer Metas Rev 2000;19:19 -27.
14. Sun LK, Beck-Schimmer B, Oertli B, et al. Hyaluronan-induced cyclooxygenase-2 expression promotes thromboxane A2 production by renal cells. Kidney Int 2001;59:190-196.
15. Uefuji K, Ichikura T, Mochizuki H. Expression of cyclooxygenase-2 in human gastric adenomas and adenocarcinomas. J Surg Oncol 2001;76:26-30.
16. Greenberg ER, Baron JA, Freeman DH, et al. Reduced risk of large-bowel adenomas among aspirin users. J Natl Cancer Inst 1993;85:912-916.
17. Giovannucci E, Egan KM, Hunter DJ, et al. Aspirin and the risk of colorectal cancer in women. N Engl J Med 1995;333:609-614.
18. Thun MJ. NSAID use and decreased risk of gastrointestinal cancers. Gastroenterol Clin N Am 1996;25: 333-348.
19. Schreinemachers DM, Everson RB. Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology 1994;5:138-146.